CORC

浏览/检索结果: 共262条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Mapping diffuse emission in lyman UV band 会议论文
Virtual, Online, CA, United states, 2020-12-14
作者:  Ji, Li;  Lou, Zheng;  Zhang, Jinlong;  Qiu, Keqiang;  Li, Shuangying
收藏  |  浏览/下载:66/0  |  提交时间:2021/02/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:46/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
Order-aware embedding neural network for CTR prediction 会议论文
作者:  Guo, Wei;  Han, Jianhua;  Tang, Ruiming;  Yang, Wen;  Guo, Huifeng
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05
Current treatment for low-risk prostate cancer in China: a national network survey 会议论文
作者:  Wei, Y.;  Liu, L.;  Li, X.;  Song, W.;  Zhong, D.
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:38/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:30/0  |  提交时间:2019/12/05
Current treatment for low-risk prostate cancer in China: a national network survey 会议论文
作者:  Wei, Y.;  Liu, L.;  Li, X.;  Song, W.;  Zhong, D.
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Cytotoxic and neuroprotective activities of constituents from Alternaria alternate, a fungal endophyte of Psidium littorale 会议论文
BIOORGANIC CHEMISTRY, 2019-09-01
作者:  Xu, Jian;  Hu, Yun-Wei;  Qu, Wei;  Chen, Ming-Hua;  Zhou, Liang-Sheng
收藏  |  浏览/下载:17/0  |  提交时间:2020/01/03


©版权所有 ©2017 CSpace - Powered by CSpace